Guide to BioTerminology 2nd edition - - BioPharm International


Guide to BioTerminology 2nd edition

BioPharm International

Biopharmaceutical development, manufacturing, and analytical methods use a variety of buffer solutions.
amino acid analysis Hydrolysis of a protein or peptide into its individual residues (free amino acids), followed by chromatographic separation and UV-vis detection for analytical purposes.

amino acids A class of 20 naturally occurring hydrocarbon molecules that combine to form proteins in living things. They include alanine (A), aspartic acid or asparagine (B), cysteine (C), glutamic acid (Z) or glutamine (Q), phenylalanine (P), glycine (G), histidine (H), isoleucine (I), lysine (K), leucine (L), methionine (M), proline (P), arginine (R), serine (S), threonine (T), valine (V), tryptophan (W), and tyrosine (Y). (Those are the so-called normal amino acids; others have been synthesized and are used in medicinal chemistry.) They are incorporated into proteins by transfer RNA according to the genetic code.

amorphous Having no apparent shape or order; noncrystalline.

ampholyte An electrolyte that can be either positively or negatively charged, depending on the pH of its medium.

amphoteric A substance that has both acid and base properties; amphoteric molecules can accept or donate protons to act as an acid or a base.

ampule A small, sterile glass vessel with an airtight seal that contains a single drug dose.

anaerobic Growing in the absence of air or oxygen. Some anaerobic organisms are killed by brief exposure to oxygen, whereas it may simply retard or stop the growth of others.

Blotting methods make electrophoresis results permanent.
analytical methods Processes used to analyze or characterize a mixture, a compound, or an unknown material.

anion A negatively charged ion (having more electrons than protons).

annual review An evaluation, conducted at least annually, which assesses the quality standards of each drug product to determine the need for changes in drug product specifications or manufacturing or control procedures. [FDAQSDG]

anodes Positive electrodes; negative ions (anions) migrate carrying electric current toward positive anodes.

antibody An infection-fighting protein molecule that tags, neutralizes, and helps destroy foreign microorganisms or toxins. Also known as immunoglobulins, antibodies are produced by the immune system in response to antigens.

antifoam agent A chemical added to a fermentation broth to counteract the foaming (bubbles) that can be caused by mixing, sparging, or stirring.

antigen Any agent that reacts specifically with an antibody. Each antigen may contain more than one site capable of binding to a particular antibody. See immunogen.

antigenicity The capacity of a substance to induce the formation of antibodies or to elicit an immune response when injected into an animal.

API Active product intermediate; the chemical entity that has the drug activity and structure, but is not yet formulated with excipients.

aprotinin A polypeptide that inhibits (blocks the action of) serine proteases.

aqueous solution A solvent solution made with water.

Arg Arginine, one of 20 naturally occurring amino acids.

artificial chromosome DNA synthesized in chromosomal form for use as an expression vector.

aseptic Sterile, free from bacteria, viruses, and other pathogenic contaminants.

Asn Asparagine, one of over 20 naturally occurring amino acids.

blog comments powered by Disqus



Bristol-Myers Squibb and Five Prime Therapeutics Collaborate on Development of Immunomodulator
November 26, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
Author Guidelines
Source: BioPharm International,
Click here